Physician profile
David T Yucha
NPI 1164624797
$131,344.72
in general payments reported to CMS, 2019-2025
20 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62K · 2020: $296 · 2021: $32K · 2022: $20K · 2023: $4,038 · 2024: $2,240 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $16K · Food and Beverage: $1,682 · Travel and Lodging: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,500.00 |
| Food and Beverage | $1,681.99 |
| Travel and Lodging | $834.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $104,943.88 | 2019-2025 | Tricera Handpiece, Juggerknotless Soft Anchor, Gel-One Cross-Linked Hyaluronate |
| Pacira Therapeutics, INC. | $20,515.64 | 2019-2021 | |
| Acelrx Pharmaceuticals, INC. | $2,036.33 | 2021 | |
| Medical Device Business Services, INC. | $1,755.00 | 2022 | |
| Stryker Corporation | $912.90 | 2019-2025 | Inspace |
| Medacta USA, INC. | $478.11 | 2021 | |
| Depuy Synthes Sales INC. | $169.10 | 2019-2025 | Monovisc, Orthovisc |
| Eclipse Technology Solutions INC. | $140.02 | 2023-2025 | |
| Avanos Medical | $80.30 | 2021-2022 | |
| Heraeus Medical, LLC. | $56.71 | 2023-2025 | Palacos |
| Synergy Orthopedics, LLC | $49.05 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $38.55 | 2025 | Euflexxa |
| Vertex Pharmaceuticals Incorporated | $36.03 | 2025 | |
| Fidia Pharma USA INC. | $22.98 | 2020 | |
| Kci USA, INC. | $22.89 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $19.69 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $19.10 | 2023 | Iovera, Zilretta |
| Dynasplint Systems INC. | $17.40 | 2019 | |
| Ermi LLC | $16.75 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.29 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Yucha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.